Walker James John 4

What Happened
CEO Walker James John exercised 170,000 stock options (exercise price $1.50) on Jan 28, 2026, paying $255,000 to acquire those shares. On the same day he disposed of a total of 195,000 common shares in multiple open-market trades for aggregate proceeds of about $6,637,822 (individual sales ranged from $33.12 to $35.37; weighted-average prices are reported per line). The Form 4 also lists a 170,000-share derivative disposal at $0.00 related to the option conversion (see footnote F1).

Key Details

• Transaction date: January 28, 2026; Form 4 filed January 30, 2026 (filed within the typical 2‑business‑day window).
• Options exercised: 170,000 shares @ $1.50 each = $255,000 (footnote F1).
• Open-market sales: 195,000 shares sold across multiple trades for total cash proceeds ≈ $6,637,822. Individual reported sale lines and proceeds:
  • 86,098 @ $33.64 = $2,896,664 (F3: trades ranged $33.12–$34.12)
  • 76,171 @ $34.37 = $2,618,058 (F4: $34.13–$34.94)
  • 7,731 @ $35.26 = $272,615 (F5: $35.24–$35.37)
  • 13,581 @ $33.66 = $457,135 (F6: $33.15–$34.145)
  • 10,609 @ $34.38 = $364,779 (F7: $34.17–$34.89)
  • 810 @ $35.27 = $28,571 (F8: $35.25–$35.35)
• Reported derivative disposition: 170,000 shares @ $0.00 (listed as disposed; see F1 for exercise details).
• 10b5‑1 plan: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted in September 2025 (footnote F2).
• Weighted-average prices shown on the Form 4; footnotes provide intra‑day price ranges and the reporting person’s undertaking to provide trade‑by‑trade details on request.
• Shares owned after the transactions: not specified in the materials provided.

Context

• This was an option exercise paired with substantial open‑market selling on the same day. The exercise involved paying the $1.50 strike for 170,000 options; the large open‑market sales generated roughly $6.64M in proceeds. The reported $0.00 derivative disposition is tied to the exercise per the filing footnote (F1) and may reflect conversion/settlement actions described in the filing.
• Sales conducted under a pre‑arranged 10b5‑1 plan are generally planned in advance and are not, by themselves, a clear signal of the insider’s current view of the company.
• All figures are taken from the Form 4 (Accession 0001493152-26-004580); for precise trade‑by‑trade prices the reporting person has agreed to provide details to the SEC staff or security holders upon request.